Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.10, Iss.4, 2005-11, pp. : 827-844

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allosteric Modulators for the Treatment of Schizophrenia: Targeting Glutamatergic Networks

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 26-54

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamatergic Neurotransmission As Molecular Target of New Anticonvulsants

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-05 ,pp. : 971-993

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: New Treatment Strategies in Schizophrenia Beyond Dopamine: Glutamatergic Neurotransmission and More (Guest Editor: Christoph Mulert & Elizabeth Scarr)]

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1474-1475

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for schizophrenia

By Biedermann Falko Fleischhacker W Wolfgang

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 2, 2011-06 ,pp. : 271-282

Informa Healthcare

Access to resources Recommend Favorite

The Glutamatergic Neurotransmission in the Central Nervous System

Current Medicinal Chemistry, Vol. 19, Iss. 9, 2012-03 ,pp. : 1269-1276

Bentham Science Publishers

Access to resources Recommend Favorite